Aquiline's Flourish Deal Puts Cash Sweeps in the Boardroom

The most consequential wealth-management deal this week was not a liftout at all; it was Aquiline's acquisition of Flourish, the cash-sweep platform that RIAs use to put uninvested client balances to work. The transaction is a single line in a deal log, but it moves a set of disclosures into a different room. The revenue-sharing arrangements Flourish has with Carson, Mariner, and Focus are no longer a back-office detail. They are now an input to a private equity owner's return model, and that changes what a board must ask about the cash on its clients' books.

Flourish is a cash-sweep platform for RIAs. Its economics, by disclosed design, rest on revenue splits with partner firms—Carson, Mariner, and Focus are the names in the disclosure. When client cash sits in the sweep, the yield it produces is divided among the platform, the RIA, and the client according to terms the advisor selected. The disclosure was always there. What changed this week is who now owns the other side of the split.

The new owner, Aquiline, is a private equity firm. Private equity ownership is not inherently good or bad for an advisor's clients, but it does alter the pressure on a product line. A sponsor that buys a platform with a return mandate will look for ways to hold or expand the economics of each revenue line, and the sweep yield that clients receive is one of the few places where a basis point gained by the platform is a basis point not earned by the client. That makes the supply of client cash a more active negotiation than it was when the counterparty was an independent fintech.

For an RIA, the fiduciary duty runs to the client, not to the platform. A revenue share that pays the firm a portion of the interest on idle balances is not automatically a violation, but it is a conflict that must be disclosed, managed, and justified. Under an independent platform, that conflict was often static: the economics were set, the advisor disclosed the arrangement, and the practice moved on. Under a private equity owner, the economics are likely to be re-examined, and the advisor cannot assume the status quo will hold.

The question is not whether a revenue share exists—the disclosures are on the table—but whether the terms were negotiated when the counterparty had a different incentive set. Advisors should treat the deal as the moment to pull the sweep agreement out of the file and ask whether the split still reflects the value the platform actually delivers. That is not a compliance exercise. It is a pricing decision about a product that competes with every other cash instrument a client can hold.

The practical discipline is the same one a fixed-income committee applies to bonds. A sweep account should be compared to the next best alternative—a money-market fund, a Treasury bill, or a separately managed cash account—on yield after the revenue split, not before. If the net yield to the client is lower than the alternative by more than the convenience justifies, the advisor should document the reason or move the cash. The benchmark is not what the platform pays. It is what the client keeps.

Advisors should also renegotiate the disclosure. The revenue-sharing arrangement with Flourish, now under Aquiline, may have been signed when the platform needed scale and the advisor had alternatives. The advisor's leverage is the same as always: client balances can move. Before that leverage disappears, firms should ask for a reconciliation of what the platform earns, what the RIA earns, and what the client earns on each dollar swept. That is not a regulatory formality; it is the only way to know whether the split is still defensible once a sponsor is measuring the same line item.

Most RIAs treat cash as the residual of the investment process—whatever is left before or after a trade. The Flourish deal is a reminder that cash is also a product, with a yield, a term, a credit risk, and a conflict. A board that treats idle balances as an afterthought is outsourcing a yield decision to a counterparty with a profit motive. The correct posture is to put cash on the asset-allocation agenda with the same rigor as the bond sleeve: what is the target, what is the benchmark, and who captures the spread.

The right response to the Aquiline-Flourish deal is not to abandon cash sweeps or to assume something is wrong. It is to make the cash line item earn its place. That means benchmarking the net yield against a money-market fund, renegotiating the disclosed split, and writing the conclusion in the client file as if a regulator or a client will read it. The deal did not create the conflict; it changed the counterparty. Advisors who treat that change as a boardroom question will be the ones whose fee model survives the next basis point.

The first test is the next sweep disclosure a firm receives from Flourish. Read it before signing, and read it as if the yield belongs to the client, because it does.